Prosecution Insights
Last updated: April 19, 2026
Application No. 17/876,663

BIOPOLYMER COMPOSITIONS INCORPORATING POLY(3-HYDROXYPROPIONATE)

Final Rejection §103§112
Filed
Jul 29, 2022
Examiner
BUTTNER, DAVID J
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
DANIMER IPCO, LLC
OA Round
2 (Final)
64%
Grant Probability
Moderate
3-4
OA Rounds
2y 9m
To Grant
68%
With Interview

Examiner Intelligence

Grants 64% of resolved cases
64%
Career Allow Rate
734 granted / 1148 resolved
-1.1% vs TC avg
Minimal +4% lift
Without
With
+4.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
49 currently pending
Career history
1197
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
55.6%
+15.6% vs TC avg
§102
7.8%
-32.2% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1148 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Amended claim 18 now reads on the elected 1st copolymer. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1 and 3-19 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 requires “both” (presumably both 1st and 2nd polymers) not have units of 3-hydroxypropionate. This contradicts the requirement that the 1st polymer be from 3-hydroxypropionate. ”Both” could not be referring to the 3-hydroxyalkanoate or 4-hydroxyalkanoate because 3-hydroxypropionate is a distinct compound from 4-hydroxyalkanoates. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1,4-6,8,9 and 13-19 rejected under 35 U.S.C. 103 as being unpatentable over Li 2011/0135863. Li claims (#1) an article of 5-95% polylactic acid (ie applicant’s 3rd polymer) and 95-5% polyhydroxyalkanoate. The polyhydroxyalkanoate (claim 3) is one or more of poly-3-hydroxypropionate (ie applicant’s 1st polymer), poly-4-hydroxybutyrate (ie applicant’s 2nd polymer), poly-3-hydroxyvalerate (ie applicant’s 2nd polymer), poly-3-hydroxyhexananoate (ie applicant’s 2nd polymer), poly-4-hydroxyhexanoate (ie applicant’s 2nd polymer). Although no example meets applicant’s ternary mixture, a mixture of polylactic acid with any two of Li’s polyhydroxyalkanoates would have been prima facie obvious. In regards to applicant’s dependent claims: The ratio of the two polyhydroxyalkanoates is not given, but any ratio would have been prima facie obvious. Poly-3-hydroxyvalerate, poly-3-hydroxyhexanoate and poly-4-hydroxyhexanoate have C2, C3 and C2 branches respectively – meeting applicant’s claim 9. Stearamide may be added (paragraph 46) may be added – meeting applicant’s claim 13. Adipate plasticizers (paragraph 46) may be added – meeting applicant’s claim 14. Talc, clay etc (paragraph 55) may be added – meeting applicant’s claim 15. All three of the polymers are aliphatic polyesters – meeting applicant’s claim 16. Additionally, aliphatic polyester plasticizers may be added (paragraph 46). Nucleating agents may be added (paragraph 51) – meeting applicant’s claim 17. Catalysts and crosslinkers may be added (paragraph 51) – meeting applicant’s claim 18. Various molded articles may be made (claim 19 of Li)– meeting applicant’s claim 19. Applicant's arguments filed 2/4/26 have been fully considered but they are not persuasive. Applicant argues that the prior rejections lack the newly required polylactic acid. This is convincing, but requires the new rejection(s). All withdrawn claims should be rigorously reviewed for proper dependency and suitability for re-joinder. Withdrawn claims that cannot be allowed should be cancelled along with any after final amendment. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DAVID J BUTTNER whose telephone number is (571)272-1084. The examiner can normally be reached M-F 9-3pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DAVID J BUTTNER/Primary Examiner, Art Unit 1765 3/3/26
Read full office action

Prosecution Timeline

Jul 29, 2022
Application Filed
Sep 11, 2025
Non-Final Rejection — §103, §112
Feb 04, 2026
Response Filed
Mar 03, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12583972
NON-ISOCYANATE POLYURETHANE ELASTOMERS AND COMPOSITIONS COMPRISING SUCH ELASTOMERS
2y 5m to grant Granted Mar 24, 2026
Patent 12577446
DIMENSIONALLY STABLE, WIPE-ON, SEMI-CRYSTALLINE-POLYESTER-BASED ADHESIVE COMPOUND
2y 5m to grant Granted Mar 17, 2026
Patent 12570800
POLYAMIDES HAVING CYCLIC TERPENOID SUBSTRUCTURES
2y 5m to grant Granted Mar 10, 2026
Patent 12540245
WATER REPELLENT COMPOSITION, METHOD FOR PRODUCING WATER REPELLENT COMPOSITION, AND FIBER PRODUCT
2y 5m to grant Granted Feb 03, 2026
Patent 12534575
OPTICAL POLYMER AND LENS INCLUDING SAME
2y 5m to grant Granted Jan 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
64%
Grant Probability
68%
With Interview (+4.0%)
2y 9m
Median Time to Grant
Moderate
PTA Risk
Based on 1148 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month